The global hepatitis testing/diagnostic market size is expected to reach USD 4.36 Billion at a steady revenue CAGR of 4.7% in 2030, according to latest analysis by Emergen Research. Market revenue growth is primarily driven by factors such as growing burden of hepatitis, introduction of molecular diagnostics for diagnosis of hepatitis, increasing awareness regarding this disease, and rising awareness regarding commercially available advanced products. Hepatitis is an inflammation of liver, commonly caused by hepatitis virus. Hepatitis testing is conducted to determine genotype of hepatitis triggering the ailment and also helps in determining best suited treatment for patient. Point-Of-Care (POC) testing helps to complete screening procedure without the need for a second visit and, in some cases, without leaving one’s house, which when combined with quick findings, lowers risk of problems and transmission. For instance, research has shown that individuals who monitor blood thinners, such as warfarin at home, report less severe side effects from medication. In addition, POC testing aids in reducing spread of infectious pathogens by delivering quick results with little contact and reducing unneeded admissions to healthcare facilities. Minimizing physical contact and immediate self-isolation are major strategies to stop the spread of many infectious diseases including COVID-19.

In order to better position themselves in the global Hepatitis Testing Diagnostic Market, the Hepatitis Testing Diagnostic Market study will offer readers, stakeholders, and enterprises detailed information about market size, revenue growth, and general market dynamics. Along with market segmentations based on things like product type, application, and regional bifurcation, it also includes comprehensive information on important considerations, limits, limitations, and problems.

To receive a sample copy of this report, visit @ https://www.emergenresearch.com/request-sample/1492

The study outlines the rapidly evolving and growing market segments along with valuable insights into each element of the industry. The industry has witnessed the entry of several new players, and the report aims to deliver insightful information about their transition and growth in the market. Mergers, acquisitions, partnerships, agreements, product launches, and joint ventures are all outlined in the report.

The leading market contenders listed in the report are:

Abbott, F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories, Inc., Siemens Healthcare GmbH, DiaSorin S.p.A, Qiagen, Danaher, Grifols, S.A., Biomerieux , and Ortho Clinical Diagnostics

Target Audience of the Global Hepatitis Testing Market Report:

• Key Market Players
• Investors
• Venture capitalists
• Small- and medium-sized and large enterprises
• Third-party knowledge providers
• Value-Added Resellers (VARs)
• Global market producers, distributors, traders, and suppliers
• Research organizations, consulting companies, and various alliances interested in this sector
• Government bodies, independent regulatory authorities, and policymakers

Get a discount on the Global Hepatitis Testing Market report @ https://www.emergenresearch.com/request-discount/1492

Major Geographies Analyzed in the Report:

• North America (U.S., Canada)
• Europe (U.K., Italy, Germany, France, Rest of EU)
• Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
• Latin America (Chile, Brazil, Argentina, Rest of Latin America)
• Middle East Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

Market Segmentations of the Hepatitis Testing Market

This market is segmented based on Types, Applications, and Regions. The growth of each segment provides accurate forecasts related to production and sales by Types and Applications, in terms of volume and value for the period between 2022 and 2030. This analysis can help readers looking to expand their business by targeting emerging and niche markets. Market share data is given on both global and regional levels. Regions covered in the report are North America, Europe, Asia Pacific, Latin America, and Middle East Africa. Research analysts assess the market positions of the leading competitors and provide competitive analysis for each company. For this study, this report segments the global Hepatitis Testing market on the basis of product, application, and region:

Segments Covered in this report are:

• Disease Type Outlook (Revenue, USD Million; 2019–2030)
• Hepatitis B (HBV)
• Hepatitis C (HCV)
• Other Hepatitis Diseases

• Technology Outlook (Revenue, USD Million; 2019–2030)
• Enzyme-Linked Immunosorbent Assay (ELISA)
• Rapid Diagnostic Tests (RDT)
• Polymerase Chain Reaction (PCR)
• Isothermal Nucleic Acid Amplification Technology (INAAT)
• Other Technologies

• End-Use Outlook (Revenue, USD Million; 2019–2030)
• Hospital Diagnostic Laboratories
• Blood Banks
• Other End-Use

Browse Full Report Description + Research Methodology + Table of Content + Infographics @ https://www.emergenresearch.com/industry-report/hepatitis-testing-market

Some Key Highlights From the Report

• On 29 June 2022, Liver Care Canada, a subsidiary of Mednow Inc. partnered with HepCURE, a non-profit organization and one of the country's top providers of hepatitis C screening and treatment, to achieve the goal of eradicating hepatitis C in Canada by 2030. To further enhance medication adherence and improve treatment outcomes, Liver Care Canada will now grant its patients access to HepCURE's programming and services. In addition, it will bring the liver care industry to rest of Canada outside of Ontario.
• The Hepatitis B Virus (HBV) segment is expected to account for largest revenue share in the global market over the forecast period. Blood tests can determine whether someone has acute or chronic hepatitis B and can also let a doctor know about the condition. A simple blood test can be used to determine one's immunity to this disease. A specific ultrasound technique called transient elastography can also be used to assess the severity of liver injury. A tiny sample of patient's liver may also be taken for testing to screen for HBV-related liver damage. A small needle is inserted through patient's skin into their liver during this surgery and a small portion of liver tissue is extracted for laboratory analysis.
• The Enzyme-Linked Immunosorbent Assay (ELISA) segment is expected to account for highest revenue share in the global market over the forecast period. The term ELISA refers to an immunoassay that uses enzymes and a standard laboratory test is performed to identify antibodies in the blood. Body's immune system creates an antibody when it detects harmful substances, also known as antigens. HBV infection is a hazard for public health around the world. Hepatitis B Surface Antigen (HBSA) is detected by ELISA, the most used serological test for detecting HBV infection (HbsAg).
• The hospital diagnostic laboratories segment is expected to account for large revenue share over the forecast period. This is due to availability of state-of-the-art facilities and improvements in healthcare infrastructure in emerging countries. Another factor driving market growth is emergence of hospitals that specialize in hepatitis testing and diagnosis. In addition, number of hepatitis testing/diagnosis facilities installed in hospitals and quantity of individual that visit hospital for such testing are also expected to drive market growth.
• The North America market is expected to account for largest revenue share during the forecast period attributed to increasing activities by key market players in countries in this region. For instance, Immediate Spin Crossmatch (ISXM), a tool for identifying donor-to-recipient incompatibility in blood transfusions, is now available on the company's ORTHO VISION and ORTHO VISION MAX Analyzers, according to Ortho Clinical Diagnostics, one of the largest pure-play In Vitro Diagnostics (IVD) companies in the world.

Additional information offered by the report:

• Along with a complete overview of the global Hepatitis Testing market, the report provides detailed scrutiny of the diverse market trends observed on both regional and global levels.
• The report elaborates on the global Hepatitis Testing market size and share governed by the major geographies.
• It performs a precise market growth forecast analysis, cost analysis, and a study of the micro- and macro-economic indicators.
• It further presents a detailed description of the company profiles of the key market contenders.

Request Customization as per your specific requirement@ https://www.emergenresearch.com/request-for-customization/1492

Thank you for reading our report. Customization of the report is available according to the requirements of our clients. Kindly get in touch with us to know more about the customization options, and our team will ensure the report is tailored according to your needs. 

Latest Published Reports by Emergen Research:

interventional cardiology market             

https://www.emergenresearch.com/industry-report/interventional-cardiology-market

small modular reactor market   

https://www.emergenresearch.com/industry-report/small-modular-reactor-market

cell-free dna testing market       

https://www.emergenresearch.com/industry-report/cell-free-dna-market

smart glass market         

https://www.emergenresearch.com/industry-report/smart-glass-market

biometrics market          

https://www.emergenresearch.com/industry-report/biometrics-market

diabetic care market      

https://www.emergenresearch.com/industry-report/diabetic-care-market

human centric lighting market   

https://www.emergenresearch.com/industry-report/human-centric-lighting-market

needle coke market       

https://www.emergenresearch.com/industry-report/needle-coke-market

automated breast ultrasound market     

https://www.emergenresearch.com/industry-report/automated-breast-ultrasound-market

direct-to-consumer genetic testing market          

https://www.emergenresearch.com/industry-report/direct-to-consumer-genetic-testing-market

About Us:

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Visit for More Insights: https://www.emergenresearch.com/insights

Explore Our Custom Intelligence services | Growth Consulting Services

Latest Report: vaccine market, functional fibers market

Trending Title: diabetic care market, autorefractor market